Journal of Antimicrobial Chemotherapy logo Oxford University Press logo

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.

Publisher: Oxford University Press

Volume 50, Number 1, July 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Identification of PSE and OXA bgr-lactamase genes in Pseudomonas aeruginosa using PCR–restriction fragment length polymorphism
pp. 11-18(8)
Authors: Bert, Frédéric; Branger, Catherine; Lambert-Zechovsky, Nicole

Two novel assays for the detection of haemin-binding properties of antimalarials evaluated with compounds isolated from medicinal plants
pp. 25-31(7)
Authors: Steele, J. C. P.; Phelps, R. J.; Simmonds, M. S. J.; Warhurst, D. C.; Meyer, D. J.

Activity of cefditoren against respiratory pathogens
pp. 33-41(9)
Authors: Clark, Catherine L.; Nagai, Kensuke; Dewasse, Bonifacio E.; Pankuch, Glenn A.; Ednie, Lois M.; Jacobs, Michael R.; Appelbaum, Peter C.

Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model
pp. 51-58(8)
Authors: Purswani, Murli U.; Eckert, Susan J.; Arora, Harman K.; Noel, Gary J.

Macrolide-treated Pseudomonas aeruginosa induces paradoxical host responses in the lungs of mice and a high mortality rate
pp. 59-66(8)
Authors: Kobayashi, Takao; Tateda, Kazuhiro; Matsumoto, Tetsuya; Miyazaki, Shuichi; Watanabe, Akira; Nukiwa, Toshihiro; Yamaguchi, Keizo

Pharmacokinetic/pharmacodynamic modelling of ciprofloxacin 250 mg/12 h versus 500 mg/24 h for urinary infections
pp. 67-72(6)
Authors: Sánchez Navarro, M. Dolores; Sayalero Marinero, M. Luisa; Sánchez Navarro, Amparo

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement
pp. 73-77(5)
Authors: Lovering, A. M.; Zhang, J.; Bannister, G. C.; Lankester, B. J. A.; Brown, J. H. M.; Narendra, G.; MacGowan, A. P.

Cefepime plus amikacin versus piperacillin–tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial
pp. 79-88(10)
Authors: Sanz, Miguel A.; López, Javier; Lahuerta, Juan J.; Rovira, Montserrat; Batlle, Montserrat; Pérez, Cristina; Vázquez, Lourdes; Julià, Antonio; Palau, Javier; Gutiérrez, Martín; Capote, Francisco J.; Ramos, Fernando; Benlloch, Luis; Larrea, Luis; Jarque, Isidro

In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci
pp. 89-93(5)
Authors: Johnson, Alan P.; Warner, Marina; Livermore, David M.

Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents
pp. 95-100(6)
Authors: Peric, Mihaela; Lin, Gengrong; Clark, Catherine L.; Jacobs, Michael R.; Appelbaum, Peter C.

Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents
pp. 101-105(5)
Authors: Ednie, Lois M.; Jacobs, Michael R.; Appelbaum, Peter C.

2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ
pp. 111-114(4)
Authors: White, E. Lucile; Suling, William J.; Ross, Larry J.; Seitz, Lainne E.; Reynolds, Robert C.

Susceptibility testing of Aspergillus spp. by means of an automated blood culture system
pp. 115-117(3)
Authors: Rath, P.-M.; Freise, J. M.; Ansorg, R.

Penicillin tolerance amongst non-toxigenic Corynebacterium diphtheriae isolated from cases of pharyngitis
pp. 125-128(4)
Authors: von Hunolstein, C.; Scopetti, F.; Efstratiou, A.; Engler, K.

In vitro anti-Helicobacter pylori activity of BAS-118, a new benzamide derivative
pp. 129-132(4)
Authors: Kobayashi, Intetsu; Muraoka, Hiroe; Hasegawa, Miyuki; Saika, Takeshi; Nishida, Minoru; Kawamura, Makoto; Ando, Ryoichi

Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo
pp. 133-136(4)
Authors: Koga, Tetsufumi; Inoue, Harumi; Ishii, Chika; Okazaki, Yoko; Domon, Haruki; Utsui, Yukio

Biocide abuse and antimicrobial resistance: being clear about the issues
pp. 137-139(3)
Authors: Gilbert, Peter; McBain, Andrew J.; Bloomfield, Sally F.

Reply
pp. 139-140(2)
Author: Fraise, Adam P.

In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates
pp. 140-142(3)
Authors: Valera, Lourdes; Gradelski, Elizabeth; Huczko, Elizabeth; Washo, Thomas; Yigit, Hesna; Fung-Tomc, Joan

Group B Streptococcus highly resistant to gentamicin
pp. 142-143(2)
Authors: Liddy, H.; Holliman, R.

Role of newer fluoroquinolones in lower respiratory tract infections
pp. 151-154(4)
Authors: Lode, H.; Allewelt, M.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A